230 related articles for article (PubMed ID: 36091710)
1. Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Han L; Fu S; Li J; Liu D; Tan Y
Front Med (Lausanne); 2022; 9():988566. PubMed ID: 36091710
[TBL] [Abstract][Full Text] [Related]
2. Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang L; Sang B; Zheng Z
Front Aging Neurosci; 2022; 14():985109. PubMed ID: 36204558
[TBL] [Abstract][Full Text] [Related]
3. Association between polycystic ovary syndrome and risk of non-alcoholic fatty liver disease: a meta-analysis.
Yao K; Zheng H; Peng H
Endokrynol Pol; 2023; 74(5):520-527. PubMed ID: 37779372
[TBL] [Abstract][Full Text] [Related]
4. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
Front Nutr; 2022; 9():880014. PubMed ID: 35669067
[TBL] [Abstract][Full Text] [Related]
5. Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis.
Zhao J; Wu Y; Lu P; Wu X; Han J; Shi Y; Liu Y; Cheng Y; Gao L; Zhao J; Wang Z; Fan X
Front Immunol; 2022; 13():1054159. PubMed ID: 36569882
[TBL] [Abstract][Full Text] [Related]
6. Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis.
Sun Q; Zhang T; Manji L; Liu Y; Chang Q; Zhao Y; Ding Y; Xia Y
Clin Epidemiol; 2023; 15():683-693. PubMed ID: 37305378
[TBL] [Abstract][Full Text] [Related]
7. The Global Prevalence of Nonalcoholic Fatty Liver Disease and its Association With Cancers: Systematic Review and Meta-Analysis.
Muhamad NA; Maamor NH; Leman FN; Mohamad ZA; Bakon SK; Abdul Mutalip MH; Rosli IA; Aris T; Lai NM; Abu Hassan MR
Interact J Med Res; 2023 Jul; 12():e40653. PubMed ID: 37467012
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
Targher G; Byrne CD; Lonardo A; Zoppini G; Barbui C
J Hepatol; 2016 Sep; 65(3):589-600. PubMed ID: 27212244
[TBL] [Abstract][Full Text] [Related]
9. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: An updated meta-analysis.
Ling Y; Xu F; Xia X; Dai D; Xiong A; Sun R; Qiu L; Xie Z
Clin Nutr; 2021 Nov; 40(11):5531-5537. PubMed ID: 34656949
[TBL] [Abstract][Full Text] [Related]
11. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
12. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.
Kositamongkol C; Kanchanasurakit S; Auttamalang C; Inchai N; Kabkaew T; Kitpark S; Chaiyakunapruk N; Duangjai A; Saokaew S; Phisalprapa P
Front Pharmacol; 2021; 12():786596. PubMed ID: 34966282
[No Abstract] [Full Text] [Related]
13. High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Chen W; Wang M; Jing X; Wu C; Zeng Y; Peng J; Cai X
J Gastroenterol Hepatol; 2020 Dec; 35(12):2051-2065. PubMed ID: 32579269
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis.
Xue J; Xin H; Ren N; Zhou C; Yang J; Song L; Qin S
Eur J Clin Invest; 2019 Sep; 49(9):e13158. PubMed ID: 31338830
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Liang C; Yu Z; Bai L; Hou W; Tang S; Zhang W; Chen X; Hu Z; Duan Z; Zheng S
Front Endocrinol (Lausanne); 2022; 13():869579. PubMed ID: 35937795
[TBL] [Abstract][Full Text] [Related]
17. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
Trivedi HD; Lopes EW; Glissen Brown J; Dudani S; Lai M; Feuerstein JD; Pierce TT
J Clin Gastroenterol; 2023 Jul; 57(6):610-616. PubMed ID: 35648974
[TBL] [Abstract][Full Text] [Related]
18. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Asgari-Taee F; Zerafati-Shoae N; Dehghani M; Sadeghi M; Baradaran HR; Jazayeri S
Eur J Nutr; 2019 Aug; 58(5):1759-1769. PubMed ID: 29761318
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.
Liao YL; Zhu GY; Chang C
Front Cardiovasc Med; 2023; 10():1291438. PubMed ID: 38268853
[TBL] [Abstract][Full Text] [Related]
20. The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis.
Ling Q; Chen J; Liu X; Xu Y; Ma J; Yu P; Zheng K; Liu F; Luo J
Front Endocrinol (Lausanne); 2022; 13():1043169. PubMed ID: 36743937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
